Team:Vilnius-Lithuania/Experiments

EXPERIMENTS

Header

Prevention

Recovery of Escherichia coli Nissle and Lactobacillus casei BL23 cultures.
Searching for the most suitable and effective E. coli Nissle 1917 and L. casei BL23 genome editing strategy.

Detection

pET28a(+)-CP5, pET28a(+)-PPDK plasmid construction.
Recombinant CP5 production optimization

Prevention

Preparation of E. coli Nissle and L. casei BL23 competent cells.
Genome editing strategy development.

Detection

Recombinant CP5 purification.
pET28a(+)-N-His, pET28a(+)-N-His-TEV plasmid construction.

Prevention

pTRKH2+sfGFP and pTRKH2+loop+sfGFP construction for fluorescence measurements.
sgRNAs, recombination templates, primers construction in silico.

Detection

Recombinant CP5 refolding and activation.

Prevention

pTRKH2+sfGFP and pTRKH2+loop+sfGFP construction for fluorescence measurements.
pTarget receiving from our advisor and multiplication in E. coli DH5 alpha strain.

Detection

Recombinant CP5 refolding and activation.

Prevention

pTRKH2+sfGFP and pTRKH2+loop+sfGFP construction for fluorescence measurements.

Detection

ePCR preparation.
Recombinant CP5 refolding and activation.

Prevention

pTRKH2+sfGFP and pTRKH2+loop+sfGFP construction for fluorescence measurements.
pLCNICK plasmid construction with sfGFP.

Detection

ePCR preparation.
Recombinant CP5 refolding and activation.
Recombinant PPDK production optimization.

Prevention

pTRKH2+sfGFP and pTRKH2+loop+sfGFP construction for fluorescence measurements.
sgRNA and gRNA oligos annealing and ligation with pTarget plasmids.
Construction of recombination template with colicin homology arms and sfGFP insertion, reactions’ conditions optimizations.
pLCNICK plasmid construction with sfGFP.

Detection

Recombinant PPDK production optimization.

Prevention

pTRKH2+sfGFP and pTRKH2+loop+sfGFP construction for fluorescence measurements.
pTarget plasmid construction.
pLCNICK plasmid construction with sfGFP.

Detection

Recombinant PPDK solubilisation and purification.

Prevention

pTRKH2+sfGFP and pTRKH2+loop+sfGFP fluorescence measurements.
Terminator insertion to the pTRKH2+loop system.
pTarget amplification, purification and preparation for sequencing.
Colicin, adhE, ackA, pta, tyrP PCR from genomic DNA optimization.

Detection

Experimental PDA synthesis.
Recombinant and denatured PPDK and CP5 stabilization experiments.

Prevention

pTRKH2+TAL/4CL/CHS/CHI and pTRKH2+loop+TAL/4CL/CHS/CHI construction.
Analysis of ackA, pta, adhE, tyrP genes sequencing results and previously designed sgRNA validation.

Detection

Anti-HSA aptamer conjugation with PDA.
Testing of PDA with Anti-HSA aptamer.
Recombinant PPDK purification.

Prevention

pTRKH2+TAL+4CL+CHS+CHI and pTRKH2+loop+TAL+4CL+CHS+CHI construction.
pCas9 plasmid amplification.
Nissle electroporation with pCas9.
sfGFP insertion into L. casei.

Detection

Protein purification with magnetic beads.
SELEX preparation, first round.

Prevention

pTRKH2+TAL-sfGFP and pTRKH2+loop+TAL-sfGFP construction.
pTRKH2+TAL+4CL+CHS+CHI and pTRKH2+loop+TAL+4CL+CHS+CHI construction.
sfGFP insertion into colicin gene in E. coli Nissle 1917.
sfGFP insertion into L. casei.

Detection

SELEX rounds 1-8.

Prevention

VapXD system construction.
pTRKH2+TAL-sfGFP and pTRKH2+loop+TAL-sfGFP construction.
pTRKH2+TAL+4CL+CHS+CHI and pTRKH2+loop+TAL+4CL+CHS+CHI construction.
AckA, pta, adhE, tyrP knockouts creation.

Detection

Aptamer ligation into pUC19 for Sanger sequencing.
NGS preparation.

Prevention

VapXD system construction.
pTRKH2+TAL-sfGFP and pTRKH2+loop+TAL-sfGFP construction.
pTRKH2+TAL+4CL+CHS+CHI and pTRKH2+loop+TAL+4CL+CHS+CHI construction.
AckA, pta, adhE, tyrP knockouts and their combinations creation.

Detection

NGS preparation.

Prevention

VapXD serial dilution spotting.
pTRKH2+TAL-sfGFP and pTRKH2+loop+TAL-sfGFP fluorescence measurements.
pTRKH2+TAL+4CL+CHS+CHI and pTRKH2+loop+TAL+4CL+CHS+CHI construction.
Fusion protein construction.
AckA, pta, adhE, tyrP knockouts and their combinations creation.

Detection

Sanger sequencing data analysis.
NGS preparation.

Prevention

pTRKH2+TAL-sfGFP and pTRKH2+loop+TAL-sfGFP fluorescence measurements.
VapXD serial dilution spotting.
pTRKH2+TAL+4CL+CHS+CHI and pTRKH2+loop+TAL+4CL+CHS+CHI construction.
AckA, pta, adhE, tyrP knockouts and their combinations creation.
VapXD system insertion into colicin gene in E. coli Nissle.

Detection

Sanger sequencing data analysis. NGS of aptamers.

Prevention

Plate reader measurements of VapXD construct in pTRKH2 plasmid.
pTRKH2+TAL+4CL+CHS+CHI and pTRKH2+loop+TAL+4CL+CHS+CHI construction by Gibson assembly.
AckA, pta, adhE, tyrP knockouts and their combinations creation.

Detection

NGS data analysis.

Prevention

Fusion protein construction.
New crRNA (for tyrP, adhE, nupG) annealing with gRNA and ligation into pTarget.
Recombination template construction for VapXD system insertion into nupG gene.
sfGFP insertion into wild type, new knockouts combinations creation with newly obtained sgRNA.
Genes of naringenin synthesis enzymes insertion into colicin and nupG genes into wild type and ackA-pta knockout strains.

Detection

Anti-PPDK aptamer conjugation with PDA.
pTRKH2+TAL+4CL+CHS+CHI and pTRKH2+loop+TAL+4CL+CHS+CHI construction by Gibson assembly.

Prevention

Plate reader measurements of VapXD construct in E. coli Nissle 1917 genome.
pTRKH2+TAL+4CL+CHS+CHI and pTRKH2+loop+TAL+4CL+CHS+CHI construction by Gibson assembly.
Genes of naringenin synthesis enzymes insertion into colicin and nupG genes into wild type and ackA-pta knockout strains.
Intermediate compounds of naringenin synthesis from E. coli Nissle 1917 growth medium and cell lysate identification by MS.

Detection

Diagnostic test assembly.
IT aptamer evaluation.

JUNE
JULY
AUGUST
SEPTEMBER
OCTOBER